The Patent Finder

Revivicor, Inc.

Also on record
Records under this name other than the patents Revivicor, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 10 of 10 · Back to Revivicor, Inc.

PatentTitleStatus Expires Confidence
US 10,300,112Transgenic ungulates expressing CTLA4-IG and uses thereof
Term ended
Term ended Aug 9, 2026 · From the USPTO record
Term endedTerm ended Aug 9, 2026From the USPTO record
US 7,795,493Porcine Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase
Term ended
Term ended May 13, 2026 · High confidence
Term endedTerm ended May 13, 2026High confidence
US 9,585,374Ungulates with genetically modified immune systems
Term ended
Term ended Oct 24, 2025 · From the USPTO record
Term endedTerm ended Oct 24, 2025From the USPTO record
US 11,085,054Ungulates with genetically modified immune systems
Term ended
Term ended Oct 24, 2025 · From the USPTO record
Term endedTerm ended Oct 24, 2025From the USPTO record
US 10,793,873Use of interfering RNA in the production of transgenic animals
Lapsed on the fee record
Ended Oct 6, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 6, 2024From the USPTO record
US 11,172,658Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferase
Term ended
Term ended Dec 17, 2023 · From the USPTO record
Term endedTerm ended Dec 17, 2023From the USPTO record
US 10,912,863Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
Term ended
Term ended Nov 23, 2023 · From the USPTO record
Term endedTerm ended Nov 23, 2023From the USPTO record
US 8,106,251Tissue Products Derived from Porcine Animals Lacking Any Expression of Functional Alpha 1,3 Galactosyltransferase
Term ended
Term ended Aug 21, 2023 · High confidence
Term endedTerm ended Aug 21, 2023High confidence
US 10,130,737Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
Term ended
Ended no later than Aug 21, 2023 · From the USPTO record
Term endedEnded no later than Aug 21, 2023From the USPTO record
US 7,531,715Double nuclear transfer method and results thereof
Term ended
Term ended Jan 13, 2020 · From the USPTO record
Term endedTerm ended Jan 13, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited